Brief: Virios Therapeutics Says Intends To Offer And Sell $2.1 Mln In Shares Of Its Common Stock
17/05/2024 21:13
May 17 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF
COMMON
STOCK TO COMMENCE PREPARATIONS FOR PLANNED IMC-2 LONG-COVID
PHASE 2B STUDY
* VIRIOS THERAPEUTICS INC: INTENDS TO OFFER AND SELL UP TO
$2.1
MILLION IN SHARES OF ITS COMMON STOCK
Source text for Eikon: ID:nGNXc7PzHH
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study